XYLT2 (xylosyltransferase 2)

2003-05-01  

Identity

HGNC
LOCATION
17q21.33
LOCUSID
ALIAS
PXYLT2,SOS,XT-II,XT2,xylT-II
FUSION GENES

Other Information

Locus ID:

NCBI: 64132
MIM: 608125
HGNC: 15517
Ensembl: ENSG00000015532

Variants:

dbSNP: 64132
ClinVar: 64132
TCGA: ENSG00000015532
COSMIC: XYLT2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000015532ENST00000017003Q9H1B5
ENSG00000015532ENST00000376550A0A0C4DFW8
ENSG00000015532ENST00000507602B4DT06
ENSG00000015532ENST00000509778D6RCT0
ENSG00000015532ENST00000511654H0YB00
ENSG00000015532ENST00000574840I3L3K2

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfateKEGGko00532
Glycosaminoglycan biosynthesis - heparan sulfate / heparinKEGGko00534
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfateKEGGhsa00532
Glycosaminoglycan biosynthesis - heparan sulfate / heparinKEGGhsa00534
Metabolic pathwaysKEGGhsa01100
Glycosaminoglycan biosynthesis, linkage tetrasaccharideKEGGhsa_M00057
Glycosaminoglycan biosynthesis, linkage tetrasaccharideKEGGM00057
MetabolismREACTOMER-HSA-1430728
Metabolism of carbohydratesREACTOMER-HSA-71387
Glycosaminoglycan metabolismREACTOMER-HSA-1630316
Heparan sulfate/heparin (HS-GAG) metabolismREACTOMER-HSA-1638091
A tetrasaccharide linker sequence is required for GAG synthesisREACTOMER-HSA-1971475
Chondroitin sulfate/dermatan sulfate metabolismREACTOMER-HSA-1793185

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA443622Carcinoma, Non-Small-Cell LungDiseaseClinicalAnnotationassociatedPD31616045
PA445846ThrombocytopeniaDiseaseClinicalAnnotationassociatedPD31616045
PA448803carboplatinChemicalClinicalAnnotationassociatedPD31616045
PA449748gemcitabineChemicalClinicalAnnotationassociatedPD31616045

References

Pubmed IDYearTitleCitations
165696442006Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II.16
260274962015Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects.8
278711152016Abnormal Proteoglycan Synthesis Due to Gene Defects Causes Skeletal Diseases with Overlapping Phenotypes.7
171947072007XT-II, the second isoform of human peptide-O-xylosyltransferase, displays enzymatic activity.6
193899162009Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum.6
269878752016Spondyloocular Syndrome: Novel Mutations in XYLT2 Gene and Expansion of the Phenotypic Spectrum.6
161646252005Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy.4
161646252005Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy.4
170033092006The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.4
180232722008Heterologous expression and biochemical characterization of soluble human xylosyltransferase II.4

Citation

Dessen P

XYLT2 (xylosyltransferase 2)

Atlas Genet Cytogenet Oncol Haematol. 2003-05-01

Online version: http://atlasgeneticsoncology.org/gene/42852/xylt2-(xylosyltransferase-2)